Stuttgart
23.03.26 | 08:46
0,001 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,006 | 0,006 | 14:25 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Episurf Medical AB's 2025 annual report is now available | 1 | Cision News | ||
| 11.03. | Notice of Extraordinary General Meeting of Episurf Medical AB (publ) | 1 | Cision News | ||
| 05.03. | Episurf Medical changes date for Annual General Meeting and financial reporting | 1 | Cision News | ||
| 27.02. | Change in number of shares and votes in Episurf Medical | 1 | Cision News | ||
| 25.02. | New US patent approval for Episurf Medical | 1 | Cision News | ||
| 24.02. | The Board of Directors of Episurf has resolved on an issue of Class B shares, convertible debentures and warrants as part of the consideration for the acquisition of real estate assets | 2 | Cision News | ||
| 23.02. | Episurf Medical AB announces outcome of exercise of warrants of series TO14 B | 1 | Cision News | ||
| EPISURF MEDICAL Aktie jetzt für 0€ handeln | |||||
| 23.02. | Members of the Nomination Committee for Episurf Medical's Annual General Meeting 2026 | 1 | Cision News | ||
| 10.02. | Episurf Medical AB: Episurf Medical announces leadership changes effective from 11 February 2026 | 162 | GlobeNewswire (Europe) | Episurf Medical (Nasdaq: EPIS B) announces leadership changes effective from 11 February 2026. Jens Andersson, elected as a Board member of Episurf at the Extraordinary General Meeting on 10 February... ► Artikel lesen | |
| 10.02. | Episurf Medical AB: Press release from extraordinary general meeting in Episurf Medical AB (publ) | 192 | GlobeNewswire (Europe) | Episurf Medical AB (publ) today 10 February 2026 held an extraordinary general meeting in Stockholm.
Approval of the acquisition etc.
The extraordinary general meeting resolved, in accordance with... ► Artikel lesen | |
| 09.02. | The exercise period for warrants of series TO14 B in Episurf commences today | 1 | Cision News | ||
| 06.02. | Episurf Medical AB: Year-end Report 1 January - 31 December 2025 | 140 | GlobeNewswire (Europe) | Significant company transformation through the purchase of real estate and continued progress in the medical device business
"We have taken significant steps forward in 2025. For the fourth quarter... ► Artikel lesen | |
| 26.01. | Episurf Medical AB: Episurf acquires properties with an agreed property value of MSEK 897 from KlaraBo | 222 | GlobeNewswire (Europe) | Episurf Medical AB (publ) (NASDAQ: EPIS B) ("Episurf" or the "Company") has today, 26 January 2026, entered into an agreement regarding the acquisition of a property portfolio consisting of residential... ► Artikel lesen | |
| 08.01. | Episurf has completed the first closing of the acquired real estate assets, convenes an extraordinary general meeting and announces a board change | 7 | Cision News | ||
| 08.01. | Notice of Extraordinary General Meeting of Episurf Medical AB (publ) | 1 | Cision News | ||
| 30.12.25 | Episurf Medical AB receives observation status | 326 | GlobeNewswire | Today, December 30, 2025, Episurf Medical AB (the "Company") issued a press release with information that the Company had entered into an agreement regarding the acquisition of all shares in Goldcup... ► Artikel lesen | |
| 30.12.25 | Episurf Medical AB: Episurf forms a new strategic business segment through the acquisition of real estate assets. The purchase price of SEK up to 1,147 million is partly paid through shares, convertibles and warrants | 228 | GlobeNewswire (Europe) | The Board of Directors of Episurf Medical AB (publ) (NASDAQ: EPIS B) ("Episurf" or the "Company") has today, 30 December 2025, entered into an agreement with Goldcup 38657 AB (under name change to Frusipe... ► Artikel lesen | |
| 18.11.25 | Update on Episurf Medical's MTP implant | 3 | Cision News | ||
| 02.11.25 | Board Member Resigns from the Board of Episurf Medical | 2 | Cision News | ||
| 24.10.25 | Episurf Medical AB: Interim Report 1 January - 30 September 2025 | 187 | GlobeNewswire (Europe) | Strong US growth in gross-order intake and customer base
Significantly improved financial results
Continued focus on regulatory pathway for MTP-implant
"This is my first CEO statement as CEO... ► Artikel lesen |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IMUNON | 2,280 | -1,72 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| ELECTROCORE | 5,200 | -1,89 % | electroCore, Inc.: electroCore Announces Full Year 2025 Financial Results and Organizational Changes | Record full year 2025 net sales of $32.0, an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general wellness... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 19,100 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| FRESENIUS | 44,390 | -0,25 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
16.03.2026 / 17:10... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,550 | -1,88 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,060 | +0,19 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Siemens Healthineers mit einem Kursziel von 52,15 Euro auf "Outperform" belassen. Die europäische Medizintechnikbranche... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,400 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| GERRESHEIMER | 19,490 | +9,86 % | BERNSTEIN RESEARCH stuft GERRESHEIMER AG auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Gerresheimer mit einem Kursziel von 18,90 Euro auf "Underperform" belassen. Die europäische Medizintechnikbranche... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,210 | 0,00 % | Leerink reiterates Outperform on BrightSpring Health stock after investor day | ||
| CARL ZEISS MEDITEC | 23,760 | +0,76 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 28,50 Euro auf "Market-Perform" belassen. Die europäische Medizintechnikbranche... ► Artikel lesen | |
| LIFEMD | 3,900 | 0,00 % | LifeMD, Inc. - 8-K, Current Report | ||
| OTTOBOCK | 49,780 | -3,25 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock veröffentlicht Geschäftsbericht für 2025 | Vorläufige Zahlen bestätigt | Dividendenvorschlag von 0,97 Euro je Aktie | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): Jahresbericht
Ottobock veröffentlicht Geschäftsbericht für 2025 | Vorläufige Zahlen bestätigt | Dividendenvorschlag von 0,97... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,440 | +2,27 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| HEARTFLOW | 26,040 | 0,00 % | Heartflow stock price target raised to $43 by Canaccord on guidance | ||
| CO-DIAGNOSTICS | 2,550 | 0,00 % | Co-Diagnostics expands South Asia distribution territory |
Das Unternehmen EPISURF MEDICAL AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,001 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EPISURF MEDICAL AB finden Sie auf Wallstreet Online.